Home › NDC Lookup › RxCUI directory › RxCUI 2716563

Deuruxolitinib 8 MG Oral Tablet — RxCUI 2716563

RxNorm drug concept · Semantic clinical drug
RxCUI 2716563 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2716563
Official nameDeuruxolitinib 8 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Deuruxolitinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Leqselvi (deuruxolitinib) is a medication that calms the part of your immune system that's mistakenly attacking your hair follicles — which is what happens in severe alopecia areat...
  • What exactly is Leqselvi and what is it supposed to do for my hair loss?
  • Leqselvi is broken down in your body by a liver enzyme called CYP2C9. Some people are born with a version of this gene that makes the enzyme work much more slowly — they're called...
  • Why do I need a genetic test before I can start this medication?
📖 Read our full Deuruxolitinib guide →

🕸️ Concept Web — How Deuruxolitinib 8 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Deuruxolitinib 8 MG Oral Tablet RxCUI 2716563

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Deuruxolitinib 2716558
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Leqselvi 2716564
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Deuruxolitinib Oral Tablet 2716562
    • Deuruxolitinib Oral Product 2716560
    • Deuruxolitinib Pill 2716561
    • Deuruxolitinib Oral Tablet [Leqselvi] 2716568
    • Leqselvi Oral Product 2716566
    • Leqselvi Pill 2716567
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Deuruxolitinib 8 MG SCDC · 2716559
  • Deuruxolitinib Oral Tablet SCDF · 2716562
  • Deuruxolitinib Oral Product SCDG · 2716560
  • Deuruxolitinib Pill SCDG · 2716561

Brand-Name Concepts

  • Deuruxolitinib 8 MG Oral Tablet [Leqselvi] SBD · 2716569
  • Deuruxolitinib 8 MG [Leqselvi] SBDC · 2716565
  • Deuruxolitinib Oral Tablet [Leqselvi] SBDF · 2716568
  • Leqselvi Oral Product SBDG · 2716566
  • Leqselvi Pill SBDG · 2716567
  • Leqselvi BN · 2716564

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2716563 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
47335-0108-86 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (47335-108-86) LEQSELVI Sun Pharmaceutical Industries, Inc. 2025-06-25
Observed labelers: Sun Pharmaceutical Industries, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.